2018
Although the U.S. population is increasingly diverse, virtually all research studies into the diagnosis and treatment of Alzheimer’s disease and related dementias are conducted with non-Hispanic white volunteers. We will convene expert panels to develop the scientific rationale for the study of possible racial differences in the risk, expression and causes of Alzheimer’s disease, and a road map to do so. To begin, we will explore the differences between non-Hispanic whites and African Americans, the largest under-represented group in the United States.
$79,594.20
Biomarkers/Diagnostics/Studies of Risk & Resilience, Foundational
Krista L. Moulder, Ph.D.